INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 145 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q1 2023. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $551 | +8.7% | 41,037 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $507 | -99.9% | 41,037 | -28.3% | 0.00% | 0.0% |
| Q3 2022 | $797,000 | +169.3% | 57,195 | +166.7% | 0.00% | – |
| Q2 2022 | $296,000 | -70.5% | 21,442 | -65.2% | 0.00% | -100.0% |
| Q1 2022 | $1,002,000 | +45.0% | 61,615 | +45.2% | 0.00% | 0.0% |
| Q4 2021 | $691,000 | +265.6% | 42,421 | +454.3% | 0.00% | – |
| Q4 2020 | $189,000 | +626.9% | 7,653 | +1079.2% | 0.00% | – |
| Q3 2020 | $26,000 | -92.0% | 649 | -90.4% | 0.00% | – |
| Q2 2020 | $325,000 | +282.4% | 6,795 | +401.1% | 0.00% | – |
| Q1 2020 | $85,000 | – | 1,356 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |